GLOBAL HEALTH EUROPEAN AND DEVELOPING COUNTRIES CLINICAL TRIALS PARNERSHIP 3 (GLOBAL HEALTH EDCTP3) - CALL FOR PROPOSAL - Deadline 04/04/2024

Altro

Altri soggetti

04/04/2024 Scaduto

The proposals can be applied on the following calls: HORIZON-JU-GH-EDCTP3-2024-01-01 - Developing novel, innovative HIV therapeutics for reducing the disease burden of HIV in sub-Saharan Africa; HORIZON-JU-GH-EDCTP3-2024-01-02 - Research on existing Malaria vaccines and development of new promising candidates; HORIZON-JU-GH-EDCTP3-2024-01-03 - Accelerating development and integration of therapeutics against Neglected Tropical Diseases (NTDs) in sub-Saharan Africa; HORIZON-JU-GH-EDCTP3-2024-01-04 - Tackling Antimicrobial Resistance (AMR) through R&D in novel and existing antimicrobials; HORIZON-JU-GH-EDCTP3-2024-01-05 - New tools, technologies and approaches for vector control in sub-Saharan Africa; HORIZON-JU-GH-EDCTP3-2024-01-06 - Innovative digital health solutions for sub-Saharan Africa;

Deadline 04/04/2024

Non definito

Non definito

EDCTP3 European Partnership for EU-Africa Global Health The EU–Africa Global Health Partnership – the third programme of the European & Developing Countries Clinical Trials Partnership (EDCTP3) – will support international research partnerships accelerating the clinical evaluation of drugs, vaccines and diagnostics for key infectious diseases affecting sub-Saharan Africa, as well as novel approaches for surveillance and control of emerging/re-emerging infections. It will also strengthen clinical research capacity in the region. Building on the two previous EDCTP programmes, the Partnership will ensure that more people gain access to new medical interventions and help to protect regional and global health security.